BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 23333012)

  • 1. Hearing preservation after radiotherapy for vestibular schwannomas is comparable to hearing deterioration in healthy adults and is accompanied by local tumor control and a highly preserved quality of life (QOL) as patients' self-reported outcome.
    Combs SE; Welzel T; Kessel K; Habermehl D; Rieken S; Schramm O; Debus J
    Radiother Oncol; 2013 Feb; 106(2):175-80. PubMed ID: 23333012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in clinical results after LINAC-based single-dose radiosurgery versus fractionated stereotactic radiotherapy for patients with vestibular schwannomas.
    Combs SE; Welzel T; Schulz-Ertner D; Huber PE; Debus J
    Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):193-200. PubMed ID: 19604653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single fraction versus fractionated linac-based stereotactic radiotherapy for vestibular schwannoma: a single-institution experience.
    Collen C; Ampe B; Gevaert T; Moens M; Linthout N; De Ridder M; Verellen D; D'Haens J; Storme G
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e503-9. PubMed ID: 21665381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcome of stereotactic radiosurgery (SRS) in patients with acoustic neuromas.
    Combs SE; Thilmann C; Debus J; Schulz-Ertner D
    Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1341-7. PubMed ID: 16464537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of acoustic neuromas with fractionated stereotactic radiotherapy (FSRT): long-term results in 106 patients treated in a single institution.
    Combs SE; Volk S; Schulz-Ertner D; Huber PE; Thilmann C; Debus J
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):75-81. PubMed ID: 16111574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fractionated stereotactic radiotherapy of vestibular schwannomas accelerates hearing loss.
    Rasmussen R; Claesson M; Stangerup SE; Roed H; Christensen IJ; Cayé-Thomasen P; Juhler M
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e607-11. PubMed ID: 22560549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome after highly advanced single-dose or fractionated radiotherapy in patients with vestibular schwannomas - pooled results from 3 large German centers.
    Combs SE; Engelhard C; Kopp C; Wiedenmann N; Schramm O; Prokic V; Debus J; Molls M; Grosu AL
    Radiother Oncol; 2015 Mar; 114(3):378-83. PubMed ID: 25702864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereotactic radiosurgery vs. fractionated radiotherapy for tumor control in vestibular schwannoma patients: a systematic review.
    Persson O; Bartek J; Shalom NB; Wangerid T; Jakola AS; Förander P
    Acta Neurochir (Wien); 2017 Jun; 159(6):1013-1021. PubMed ID: 28409393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skull base meningiomas: Long-term results and patient self-reported outcome in 507 patients treated with fractionated stereotactic radiotherapy (FSRT) or intensity modulated radiotherapy (IMRT).
    Combs SE; Adeberg S; Dittmar JO; Welzel T; Rieken S; Habermehl D; Huber PE; Debus J
    Radiother Oncol; 2013 Feb; 106(2):186-91. PubMed ID: 22906549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression of hearing loss after LINAC-based stereotactic radiotherapy for vestibular schwannoma is associated with cochlear dose, not with pre-treatment hearing level.
    van Linge A; van Os R; Hoekstra N; Heijmen B; Stienstra L; Dallenga A; Wolbers J; Mendez Romero A
    Radiat Oncol; 2018 Dec; 13(1):253. PubMed ID: 30583739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term follow-up reveals low toxicity of radiosurgery for vestibular schwannoma.
    Rutten I; Baumert BG; Seidel L; Kotolenko S; Collignon J; Kaschten B; Albert A; Martin D; Deneufbourg JM; Demanez JP; Stevenaert A
    Radiother Oncol; 2007 Jan; 82(1):83-9. PubMed ID: 17182142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fractionated vs. single-fraction stereotactic radiotherapy in patients with vestibular schwannoma : Hearing preservation and patients' self-reported outcome based on an established questionnaire.
    Kessel KA; Fischer H; Vogel MM; Oechsner M; Bier H; Meyer B; Combs SE
    Strahlenther Onkol; 2017 Mar; 193(3):192-199. PubMed ID: 27803960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gamma knife radiosurgery in younger patients with vestibular schwannomas.
    Lobato-Polo J; Kondziolka D; Zorro O; Kano H; Flickinger JC; Lunsford LD
    Neurosurgery; 2009 Aug; 65(2):294-300; discussion 300-1. PubMed ID: 19625908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiotherapy in patients with vestibular schwannoma and neurofibromatosis type 2: clinical results and review of the literature.
    Wagner J; Welzel T; Habermehl D; Debus J; Combs SE
    Tumori; 2014; 100(2):189-94. PubMed ID: 24852864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereotactic fractionated radiotherapy and LINAC radiosurgery in the treatment of vestibular schwannoma-report about both stereotactic methods from a single institution.
    Kopp C; Fauser C; Müller A; Astner ST; Jacob V; Lumenta C; Meyer B; Tonn JC; Molls M; Grosu AL
    Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1485-91. PubMed ID: 20708852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased cochlear radiation dose predicts delayed hearing loss following both stereotactic radiosurgery and fractionated stereotactic radiotherapy for vestibular schwannoma.
    Patel KS; Ng E; Kaur T; Miao T; Kaprealian T; Lee P; Pouratian N; Selch MT; De Salles AAF; Gopen Q; Tenn S; Yang I
    J Neurooncol; 2019 Nov; 145(2):329-337. PubMed ID: 31552587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fractionated stereotactic radiotherapy for acoustic neuromas: a prospective monocenter study of about 158 cases.
    Litre F; Rousseaux P; Jovenin N; Bazin A; Peruzzi P; Wdowczyk D; Colin P
    Radiother Oncol; 2013 Feb; 106(2):169-74. PubMed ID: 23219253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hearing Preservation for Vestibular Schwannomas Treated with Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy.
    Udawatta M; Kwan I; Preet K; Nguyen T; Ong V; Sheppard JP; Duong C; Romiyo P; Lee P; Tenn S; Kaprealian T; Gopen Q; Yang I
    World Neurosurg; 2019 Sep; 129():e303-e310. PubMed ID: 31132496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fractionated stereotactic radiotherapy for acoustic neuroma: single-institution experience at The Princess Margaret Hospital.
    Koh ES; Millar BA; Ménard C; Michaels H; Heydarian M; Ladak S; McKinnon S; Rutka JA; Guha A; Pond GR; Laperriere NJ
    Cancer; 2007 Mar; 109(6):1203-10. PubMed ID: 17318817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linear accelerator stereotactic radiosurgery for vestibular schwannomas: a UK series.
    Benghiat H; Heyes G; Nightingale P; Hartley A; Tiffany M; Spooner D; Geh JI; Cruickshank G; Irving RM; Sanghera P
    Clin Oncol (R Coll Radiol); 2014 Jun; 26(6):309-15. PubMed ID: 24636634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.